ASR1 Antibody

What is the molecular weight of ASK1 protein and how does this impact antibody selection?

ASK1 (also known as MAP3K5) appears as a specific band at approximately 154 kDa on Western blots under reducing conditions . When selecting an antibody, researchers should verify that it detects the appropriate molecular weight band to ensure specificity. Different antibodies may target various epitopes or domains of ASK1, so selecting one that recognizes your region of interest (such as the C-terminal domain) is critical for experimental success .

What are the functional differences between ASK1 and ASRGL1 that affect antibody applications?

ASK1 functions as a serine/threonine kinase in the MAP kinase signal transduction pathway, playing crucial roles in cellular stress responses and apoptosis . In contrast, ASRGL1 has both L-asparaginase and beta-aspartyl peptidase activity and may be involved in producing L-aspartate, which can act as an excitatory neurotransmitter in certain brain regions . These distinct functions necessitate different experimental approaches - ASK1 antibodies are frequently used in stress response and apoptosis studies, while ASRGL1 antibodies are more relevant for enzyme activity and neurotransmitter research.

What sample types have been validated for ASK1 and ASRGL1 antibody applications?

ASK1 antibodies have been validated in several sample types including cell lysates from human Burkitt's lymphoma (Raji) cell line and rat aortic endothelial cells. ASRGL1 antibodies have been tested primarily with human samples in Western blot applications . When working with new sample types, validation experiments are essential as antibody performance can vary significantly between tissue types and preparation methods.

What are the optimal storage conditions for maintaining ASK1 antibody activity?

For ASK1 antibodies, optimal storage includes:

• Long-term storage (12 months from receipt): -20 to -70°C as supplied

• Medium-term storage (1 month): 2 to 8°C under sterile conditions after reconstitution

• Extended storage (6 months): -20 to -70°C under sterile conditions after reconstitution

It is critical to use a manual defrost freezer and avoid repeated freeze-thaw cycles that can degrade antibody quality and reduce binding efficiency .

What are the recommended working dilutions for ASK1 antibody in different applications?

Based on published protocols, the following dilutions are recommended:

• Western blot: 1 μg/mL for ASK1 antibody

• Immunohistochemistry: Dilutions should be optimized for each specific antibody and tissue type

• Flow cytometry: Approximately 5 μg per sample (based on comparable antibody applications)

How should researchers optimize blocking conditions for Western blots using ASK1 antibodies?

For Western blot detection of ASK1, PVDF membranes have been successfully used with a concentration of 1 μg/mL of antibody . The protocol that successfully detected the 154 kDa ASK1 band utilized Immunoblot Buffer Group 2 under reducing conditions . When optimizing blocking, researchers should systematically test different blocking agents (BSA, non-fat milk, commercial blockers) at varying concentrations (3-5%) while maintaining consistent antibody concentration to determine conditions that minimize background while preserving specific signal.

How can researchers distinguish between specific and non-specific bands when using ASK1 antibodies in Western blots?

To confidently identify specific ASK1 bands:

• Always include positive and negative control samples

• Verify the molecular weight (approximately 154 kDa for full-length ASK1)

• Consider using a blocking peptide competition assay, similar to the approach used with S1PR1 antibodies

• Use lysates from cells with ASK1 knockdown or knockout as negative controls

• Compare results across multiple antibodies targeting different epitopes of ASK1

Non-specific bands may appear at different molecular weights or persist even in knockout/knockdown samples.

What are common causes of inconsistent results when using ASRGL1 antibodies?

Inconsistent results with ASRGL1 antibodies may stem from:

• Protein degradation during sample preparation

• Variations in ASRGL1 expression levels between different cell types

• Post-translational modifications affecting epitope accessibility

• Improper antibody storage leading to reduced activity

• Inconsistent transfer efficiency during Western blotting

To address these issues, researchers should standardize sample preparation protocols, optimize protein extraction methods for specific tissues, and validate antibody performance regularly with known positive controls.

How can researchers resolve high background issues in immunohistochemistry with ASK1 antibodies?

When experiencing high background in IHC:

• Increase blocking time and/or blocking agent concentration

• Optimize primary antibody dilution (often requires further dilution)

• Reduce secondary antibody concentration

• Include additional washing steps with detergent (0.1-0.3% Triton X-100 or Tween-20)

• Consider antigen retrieval method optimization based on the fixation method used

• Use blocking peptides to confirm specificity, similar to the approach demonstrated with S1PR1 antibodies in rat lung sections

How can ASK1 antibodies be utilized to study stress-activated protein kinase pathways in inflammatory conditions?

ASK1 antibodies can be used to investigate stress response mechanisms through:

• Immunoprecipitation to isolate ASK1 complexes with interacting proteins

• Phospho-specific ASK1 antibodies to monitor activation status

• Time-course experiments following stress induction (UV, inflammatory cytokines)

• Co-localization studies with downstream kinases (p38, JNK)

• Chromatin immunoprecipitation (ChIP) to identify transcriptional targets

Research has established that ASK1 is induced by inflammatory cytokines, UV light, and other stress stimuli to phosphorylate MAP kinase kinases that activate p38 and JNK families . Mice lacking ASK1 show resistance to stress-induced p38 and JNK activation and cell death, making this an important pathway to study in inflammatory and stress-related pathologies .

What methodologies can be used to investigate the role of ASRGL1 enzymatic activity in neurological disorders?

To study ASRGL1's role in neurological contexts:

• Combine ASRGL1 antibody-based protein detection with enzymatic activity assays

• Develop immunohistochemical mapping of ASRGL1 expression in different brain regions

• Use co-immunoprecipitation to identify protein interaction partners

• Implement proximity ligation assays to study protein-protein interactions in situ

• Design experiments to correlate ASRGL1 levels with L-aspartate concentrations

ASRGL1 has both L-asparaginase and beta-aspartyl peptidase activities and may be involved in L-aspartate production, which functions as an excitatory neurotransmitter in certain brain regions . This makes it particularly relevant for studies of neurotransmitter metabolism and neurological disorders.

How can researchers implement multiplexing techniques with ASK1 antibodies for complex signaling pathway analysis?

Advanced multiplexing approaches include:

• Multiplex immunofluorescence using antibodies raised in different host species

• Sequential immunostaining with antibody stripping between rounds

• Integration of phospho-specific ASK1 antibodies with total ASK1 and downstream target antibodies

• Mass cytometry (CyTOF) for simultaneous detection of multiple pathway components

• Combination with proximity ligation assays to detect protein-protein interactions

When designing multiplexed experiments, careful antibody selection is crucial to avoid cross-reactivity. Validation experiments should confirm that detection of each target is not affected by the presence of other antibodies in the multiplex panel.

What positive and negative controls should be included when validating a new ASK1 antibody?

When validating a new ASK1 antibody:

Positive controls:

• Raji human Burkitt's lymphoma cell lysates (demonstrated to express ASK1)

• Tissues or cells treated with stress inducers known to activate ASK1

• Recombinant ASK1 protein (particularly the region from Lys1011-Asp1196 for some antibodies)

Negative controls:

• ASK1 knockout or knockdown cell lysates

• Pre-absorption of antibody with immunizing peptide

• Isotype control antibodies

• Tissues known not to express significant levels of ASK1

How can researchers quantitatively assess ASK1 expression levels across different experimental conditions?

For quantitative assessment of ASK1 expression:

• Establish standard curves using recombinant ASK1 protein

• Implement densitometry analysis of Western blots with appropriate normalization to loading controls

• Utilize quantitative flow cytometry with calibrated beads for cellular expression

• Employ digital pathology tools for quantitative immunohistochemistry

• Consider ELISA or other immunoassays for high-throughput quantification

When comparing across conditions, maintain consistent sample preparation, antibody concentrations, and detection parameters. Biological and technical replicates are essential for statistical validity.

What considerations are important when selecting ASK1 antibodies for studying protein localization?

For localization studies:

• Choose antibodies validated for immunofluorescence or immunohistochemistry

• Verify antibody specificity through knockout/knockdown controls

• Consider using antibodies against different epitopes to confirm localization patterns

• Evaluate fixation and permeabilization protocols that preserve epitope accessibility while maintaining cellular architecture

• Include co-localization markers for cellular compartments (nucleus, mitochondria, etc.)

Cellular localization of ASK1 can change upon activation, so experimental timing is crucial when studying translocation events in response to cellular stressors.

How can flow cytometry be optimized for detection of ASK1 in different cell populations?

For flow cytometric detection of ASK1:

• Optimize fixation and permeabilization protocols for intracellular staining

• Titrate antibody concentration to determine optimal signal-to-noise ratio

• Include appropriate compensation controls when multiplexing

• Validate staining protocols with positive and negative cell populations

• Consider using fluorescence-minus-one (FMO) controls for accurate gating

The approach demonstrated for S1PR1 detection by flow cytometry in Jurkat cells provides a useful reference methodology that can be adapted for ASK1 detection .

What emerging techniques are enhancing the utility of ASK1 antibodies in single-cell analysis?

Emerging single-cell approaches include:

• Integration with single-cell RNA sequencing for correlating protein expression with transcriptomics

• Mass cytometry for high-dimensional protein profiling at single-cell resolution

• Microfluidic antibody capture for quantitative single-cell protein analysis

• In situ sequencing combined with immunofluorescence for spatial contextualization

• Live-cell imaging with fluorescently-tagged antibody fragments

These approaches are particularly valuable for understanding ASK1's role in heterogeneous cell populations responding differently to stressors.

How can researchers effectively combine genetic manipulation techniques with ASK1 antibody-based detection for mechanistic studies?

Strategies for integrated genetic-proteomic approaches:

• Use CRISPR-Cas9 to generate domain-specific mutations in ASK1 while monitoring expression and localization with antibodies

• Implement inducible expression systems with epitope-tagged ASK1 variants alongside antibody detection of endogenous protein

• Utilize optogenetic or chemogenetic tools to manipulate ASK1 activity with temporal precision while monitoring downstream effects

• Develop biosensor systems incorporating ASK1 antibody-derived binding domains

• Combine ASK1 knockdown/knockout with rescue experiments using mutant variants

These integrated approaches enable more precise dissection of ASK1 function than either genetic or antibody-based methods alone.